Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

【24h】

Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

机译：可定位的ERBB2突变独立地预测初级，ERBB2未扩增的激素受体阳性小叶乳腺癌的侵袭性表型

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：可定位的ERBB2突变独立地预测初级，ERBB2未扩增的激素受体阳性小叶乳腺癌的侵袭性表型
2. An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers [J] . June Y. Hou, Jason D. Wright, Vuthinun Achariyapota Gynecologic Oncology Reports . 2020,第2期

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献
3. The 3rd Munich breast cancer symposium. ErbB2(HER2)-positive metastasized breast cancer: Using the treatment possibilities [3. Münchner Brustkrebs-Symposium: ErbB2(HER2)-positives metastasiertes Mammakarzinom: Die therapeutischen M?glichkeiten nutzen] [J] . Noauthornameavailable Breast care . 2012,第1期

机译：第三届慕尼黑乳腺癌研讨会。 ErbB2（HER2）阳性转移性乳腺癌：使用治疗方法[3。慕尼黑乳腺癌研讨会：ErbB2（HER2）阳性转移性乳腺癌：使用治疗选择]
4. Comprehensive proteomic analyses of the effects of a novel mutation in the ErbB2 tyrosine kinase domain on breast cancer metastasis [C] . Jane OHara, Juergen Kast American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：综合蛋白质组学分析ErbB2酪氨酸激酶结构域对乳腺癌转移的影响
5. Clathrin-independent endocytosis of ErbB2 in human breast cancer cells. [D] . Barr, Daniel John. 2007

机译：人乳腺癌细胞中ErbB2不依赖网格蛋白的内吞作用。
6. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets [O] . Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro, 2020

机译：可定位的ERBB2突变状态是雌激素受体阳性逆行预后的独立标志ERBB2未扩增的原代小叶乳腺癌：公共数据集的硅分析中的回顾
7. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets [O] . Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro, 2020

机译：可定位的ERBB2突变状态是雌激素受体阳性逆行预后的独立标志，ERBB2未扩增的原代小叶乳腺癌：公共数据集的硅分析中的回顾

Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

著录项

相似文献

相关主题

期刊订阅